Recent advances on natriuretic peptide system: New promising therapeutic targets for the treatment of heart failure

Pharmacological Research

Volumn 76, Issue , 2013, Pages 190-198

  Del Ry, Silvia ^a   Cabiati, Manuela ^a   Clerico, Aldo ^b  

^a CNR   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

BNP; Cardiac endocrine function; CNP; Heart failure; Natriuretic peptides

Indexed keywords

ANARITIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANYLATE CYCLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NATRIURETIC PEPTIDE TYPE C; NESIRITIDE; RECOMBINANT BRAIN NATRIURETIC PEPTIDE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; URODILATIN;

CARDIOVASCULAR DISEASE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; ENDOTHELIUM; ENZYME DEGRADATION; GLYCOSYLATION; GOLGI COMPLEX; HEART FAILURE; HEART MUSCLE CELL; HEMODYNAMICS; HORMONAL REGULATION; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

BNP; CARDIAC ENDOCRINE FUNCTION; CNP; HEART FAILURE; NATRIURETIC PEPTIDES;

AMINO ACID SEQUENCE; ANIMALS; DRUG DISCOVERY; HEART FAILURE; HUMANS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; NATRIURETIC PEPTIDES;

EID: 84884222218     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.08.006     Document Type: Review

References (107)

1. A.J. de Bold, H.B. Borenstein, A.T. Veress, and H. Sonnenberg A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats Life Sci 28 1981 89 94 (Pubitemid 11184926)
2. A. Clerico, A. Giannoni, S. Vittorini, and C. Passino Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones Am J Physiol Heart Circ Physiol 301 2011 H12 H20
3. A. Clerico, F.A. Recchia, C. Passino, and M. Emdin Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications Am J Physiol Heart Circ Physiol 290 2006 H17 H29
4. R.L. Potter, A.R. Yoder, D.R. Flora, L.K. Antos, and D.M. Dickey Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications Handb Exp Pharmacol 191 2009 341 366
5. J.P. Goetze Biosynthesis of cardiac natriuretic peptides Results Probl Cell Differ 50 2010 97 120
6. A.M. Richards, J.G. Lainchbury, M.G. Nicholls, A.V. Cameron, and T.G. Yandle Dendroaspis natriuretic peptide: endogenous or dubious? Lancet 359 2002 5 6 (Pubitemid 34119185)
7. A.J. de Bold Natriuretic peptides gene expression and secretion in inflammation J Invest Med 57 2009 29 32
8. J.Y. Qian, A. Haruno, Y. Asada, T. Nishida, Y. Saito, and T. Matsuda Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries Circ Res 91 2002 1063 1069 (Pubitemid 35416644)
9. R.S. Scotland, M. Cohen, P. Foster, M. Lovell, A. Mathur, and A. Ahluwalia C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression Proc Natl Acad Sci USA 102 2005 14452 14457 (Pubitemid 41429718)
10. I.C. Villar, C.M. Panayiotou, A. Sheraz, M. Madhani, R.S. Scotland, and M. Nobles Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor Cardiovasc Res 74 2007 515 525 (Pubitemid 46711091)
11. J.A. Doust, P.P. Glasziou, E. Pietrzak, and A.J. Dobson A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure Arch Intern Med 164 2004 1978 1984 (Pubitemid 39390553)
12. J.A. Doust, E. Pietrzak, A. Dobson, and P. Glasziou How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review Br Med J 330 7492 2005 625
13. A. Clerico, M. Fontana, A. Ripoli, and M. Emdin Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure Adv Clin Chem 48 2009 163 169
14. P. Porapakkham, P. Porapakkham, H. Zimmet, B. Billah, and H. Krum B-type natriuretic peptide-guided heart failure therapy: a meta-analysis Arch Intern Med 170 2010 507 514
15. M. Jessup, W.T. Abraham, D.E. Casey, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
16. NICE Clinical Guideline No. 108: chronic heart failure: national clinical guideline for diagnosis and management in primary and secondary care 2010 1 222
17. K. Thygesen, J. Mair, C. Mueller, K. Huber, M. Weber, and M. Plebani Recommendations for the use of natriuretic peptides in acute cardiac care. A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care Eur Heart J 33 2012 2001 2006
18. A.M. Richards, and R.W. Troughton Use of natriuretic peptides to guide and monitor heart failure therapy Clin Chem 2012 62 71
19. F. Liang, J. O'Rear, U. Schellenberger, L. Tai, L. Tai, and M. Lasecki Evidence for functional heterogeneity of circulating B-type natriuretic peptide J Am Coll Cardiol 49 2007 1071 1078 (Pubitemid 46349497)
20. J.P. Goetze Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited Clin Chem 49 2004 1503 1510 (Pubitemid 39121217)
21. J.P. Goetze ProBNP-derived peptides in cardiac disease Scand J Clin Lab Invest 64 2004 497 510
22. I. Giuliani, F. Rieunier, C. Larue, J.F. Delagneau, C. Granire, and B. Pau Assay for measurement of intact B-type natriuretic peptide prohormone in blood Clin Chem 52 2006 1054 1061 (Pubitemid 43794417)
23. K.R. Seferian, N.N. Tamm, A.G. Semenov, K.S. Mukharyamova, A.A. Tolstaya, and E.V. Koshkina The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure Clin Chem 53 2007 866 873 (Pubitemid 46744242)
24. A. Hammerer-Lercher, B. Halfinger, B. Sarg, J. Mair, B. Puschendorf, and A. Griesmacher Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure Clin Chem 54 2008 858 865 (Pubitemid 351671596)
25. J.P. Goetze, and J.F. Rehfeld Peptide hormones and their prohormones as biomarkers Biomark Med 3 2009 335 338
26. D.J. Dries, B. Ky, A. Wu, J.E. Rame, M. Putt, and T. Cappola Simultaneous assessment of unprocessed ProBNP 1-108 in addition to processed BNP32 improves risk stratification in ambulatory patients with systolic heart failure Circ Heart Fail 3 2010 220 227
27. F. Macheret, G. Boerrigter, P. McKie, L. Costello-Boerrigter, B. Lahr, and D. Heublein Pro-B-type natriuretic peptide 1-108 circulates in the general community: plasma determinants and detection of left ventricular systolic dysfunction J Am Coll Cardiol 57 2011 1386 1395
28. W.L. Miller, M.A. Phelps, C.M. Wood, U. Schellenberger, A. van Le, and R. Perichon Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure Circ Heart Fail 4 2011 355 360
29. M. Emdin, C. Passino, and A. Clerico Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide? J Am Coll Cardiol 57 2011 1396 1398
30. A. Clerico, S. Vittorini, and C. Passino Circulating forms of the B-type natriuretic peptide prohormone: pathophysiologic and clinical considerations Adv Clin Chem 58 2012 31 44
31. S. Del Ry C-type natriuretic peptide: a new cardiac mediator Peptides 40 2012 93 98
32. C. Calvieri, S. Rubattu, and M. Volpe Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects o natriuretic peptides J Mol Med 90 2012 5 13
33. N.G. Lumsden, R.S. Khambata, and A.J. Hobbs C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target Curr Pharm Des 16 2010 4080 4088
34. Y. Takei Does the natriuretic peptide system exist throughout the animal and plant kingdom? Comp Biochem Physiol B 129 2001 559 573 (Pubitemid 32523980)
35. D.L. Vesely, and A.T. Giordano Atrial natriuretic peptide hormonal system in plants Biochem Biophys Res Commun 179 1991 695 700
36. T. Billington, M. Pharmawati, and C.A. Gehring Isolation and immunoaffinity purification of biologically active plant natriuretic peptide Biochem Biophys Res Commun 235 1997 722 725 (Pubitemid 27326551)
37. C.A. Loretz, and C. Pollina Natriuretic peptides in fish physiology Comp Biochem Physiol A 125 2000 169 187 (Pubitemid 30312913)
38. A. Kawakoshi, S. Hyodo, K. Inoue, Y. Kobayashi, Y. Takei, and Four natriuretic peptides (ANP BNP, VNP and CNP) coexist in the sturgeon: identification of BNP in fish lineage J Mol Endocrinol 32 2004 547 555
39. K. Inoue, T. Sakamoto, S. Yuge, H. Iwatani, S. Yamagami, and M. Tsutsumi Structural and functional evolution of three cardiac natriuretic peptides Mol Biol Evol 22 2005 2428 2434 (Pubitemid 41661379)
40. G.E. Woodard, J.A. Rosado, and J. Brown Expression and control of C-type natriuretic peptide in rat vascular smooth muscle cells Am J Physiol Regul Integr Comp Physiol 282 2002 R156 R165
41. T. Tan, P.M. Scholz, and H.R. Weiss Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes Life Sci 87 2010 9 16
42. T. Ichiki, G. Boerrigter, B.K. Huntley, S.J. Sangaralingham, P.M. McKie, and G.J. Harty Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis Am J Physiol Regul Integr Comp Physiol 304 2013 R102 R109
43. K. Osterbur, D.H. Yu, and A.E. de Clue Interleukin-1, tumour necrosis factor-a and lipopolysaccharide induce C-type natriuretic peptide from canine aortic endothelial cells Res Vet Sci 94 2013 478 483
44. L.R. Potter Guanylyl cyclase structure, function and regulation Cell Signal 23 2011 1921 1926
45. U. Schellenberger, J. O'Rear, A. Guzzetta, R.A. Jue, A.A. Protter, and N.S. Pollitt The precursor to B-type natriuretic peptide is an O-linked glycoprotein Arch Biochem Biophys 451 2006 160 166
46. K.R. Seferian, N.N. Tamm, A.G. Semenov, A.A. Tolstaya, E.V. Koshkina, and M.I. Krasnoselsky Immunodetection of glycosylated NT-proBNP circulating in human blood Clin Chem 54 2008 866 873 (Pubitemid 351671597)
47. D.L. Crimmins, and J.L. Kao A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein Arch Biochem Biophys 475 2008 36 41
48. A.G. Semenov, A.B. Postnikov, N.N. Tamm, K.R. Seferian, N.S. Karpova, and M.N. Bloshchitsyna Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site Clin Chem 55 2009 489 498
49. H. Shimizu, K. Masuta, K. Aono, H. Asada, K. Sasakura, and M. Tamaki Molecular forms of human brain natriuretic peptide in plasma Clin Chim Acta 316 2002 129 135 (Pubitemid 34028197)
50. H. Shimizu, K. Masuta, H. Asada, K. Sugita, and T. Sairenji Characterization of molecular forms of probrain natriuretic peptide in human plasma Clin Chim Acta 334 2003 233 239 (Pubitemid 36836080)
51. M. Emdin, C. Passino, C. Prontera, M. Fontana, R. Poletti, and A. Gabutti Comparison of brain natriuretic peptide (BNP) and amino-terminal proBNP for early diagnosis of heart failure Clin Chem 53 2007 1264 1272
52. M. Emdin, M. Fontana, R. Poletti, A. Gabutti, C. Mammini, and A. Rossi Natriuretic peptide testing in primary care patients Clin Chem Lab Med 46 2008 1533 1542
53. S. Knappe, F. Wu, M.R. Masikat, and Q. Wu Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin J Biol Chem 278 2003 52363 52370 (Pubitemid 38035826)
54. N. Dong, S. Chen, J. Yang, L. He, P. Liu, and D. Zheng Plasma soluble corin in patients with heart failure Circ Heart Fail 3 2010 207 211
55. A.G. Semenov, K.R. Seferian, N.N. Tamm, M.M. Artem'eva, A.B. Postnikov, and A.V. Bereznikova Human pro-B-type natriuretic peptide is processed in the circulation in a rat model Clin Chem 57 2011 883 890
56. 1-108 is resistan to degradation and actvates guanylyl cyclase-A with reduced potency Clin Chem 57 2011 1272 1278
57. G. Iervasi, A. Clerico, S. Berti, A. Pilo, A. Biagini, and R. Bianchi Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling Circulation 91 1995 2018 2027
58. A. Clerico, S. Vittorini, and C. Passino Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance Clin Chem Lab Med 49 2011 1949 1954
59. T. Sudoh, N. Minamino, K. Kangawa, and H. Matsuo C-type natriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain Biochem Biophys Res Commun 168 1990 863 870 (Pubitemid 20164622)
60. Z. Abassi, T. Karram, S. Ellaham, J. Winaver, and A. Hoffman Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance Pharm Ther 102 2004 223 241 (Pubitemid 38887694)
61. C.S. Barr, P. Rhodes, and A.D. Struthers C-type natriuretic peptide Peptides 17 1996 1243
62. R.S. Scotland, A. Ahluwalia, and A.J. Hobbs C-type natriuretic peptide in vascular physiology and disease Pharm Ther 105 2005 85 93
63. M. Barton, J.L. Beny, L.V. d'Uscio, T. Wyss, G. Noll, and T.F. Luscher Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries J Cardiovasc Pharmacol 31 1998 377 383 (Pubitemid 28103617)
64. S.D. Chauhan, H. Nilsson, A. Ahluwalia, and A.J. Hobbs Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor PNAS 100 2003 1426 1431 (Pubitemid 36184018)
65. T.M. Griffith Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Brit J Pharm 141 2004 881 903 (Pubitemid 38510072)
66. S. Del Ry, M. Cabiati, F. Vozzi, B. Battolla, C. Caselli, and F. Forini Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes Peptides 32 2011 1713 1718
67. Y. Ogawa, H. Itoh, Y. Yoshitake, M. Inoue, T. Yoshimasa, and T. Serikawa Molecular cloning and chromosomal assignment of the mouse C-type natriuretic peptide (CNP) gene (Nppc): comparison with the human CNP gene (NPPC) Genomics 24 1994 383 387
68. Y. Tawaragi, K. Fuchimura, S. Tanaka, N. Minamino, K. Kangawa, and H. Matsuo Gene and precursor structures of human C-type natriuretic peptide Biochem Biophys Res Commun 175 1991 645 651
69. C. Wu, F. Wu, J. Pan, J. Morser, and Q. Wu Furin-mediated processing of Pro-C-type natriuretic peptide J Biol Chem 278 2003 25847 25852 (Pubitemid 36835344)
70. J. Brown, Q. Chen, and G. Hong An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair Am J Physiol 272 1997 H2919 H2931
71. V.T. Yeung, S.K. Ho, M.G. Nicholls, and C.S. Cockram Binding of CNP-22 and CNP-5 to cultured mouse astrocytes and effects on cyclic GMP Peptides 17 1996 101 106 (Pubitemid 26048995)
72. S. Suga, K. Nakao, H. Itoh, Y. Komatsu, Y. Ogawa, and N. Hama Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" J Clin Invest 90 1992 1145 1149
73. S. Suga, H. Itoh, Y. Komatsu, Y. Ogawa, N. Hama, and T. Yoshimasa Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells - evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells Endocrinology 133 1993 3038 3041 (Pubitemid 24000770)
74. T.H. Chun, H. Itoh, Y. Ogawa, N. Tamura, K. Takaya, and T. Igaki Shear stress augments expression of C-type natriuretic peptide and adrenomedullin Hypertension 29 1997 1296 1302 (Pubitemid 27233180)
75. P.J. Hunt, A.M. Richards, E.A. Espiner, M.G. Nicholls, and T.G. Yandle Bioactivity and metabolism of C-type natriuretic peptide in normal man J Clin Endocrinol Metab 78 1994 1428 1435 (Pubitemid 24181016)
76. S.C. Palmer, T.C.R. Prikett, E.A. Espiner, T.G. Yandle, and A.M. Richards Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function Hypertension 54 2009 612 618
77. S. Del Ry, M. Cabiati, T. Stefano, G. Catapano, C. Caselli, and T. Prescimone Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients Regul Pept 166 2011 15 20
78. T.C.R. Prickett, T.G. Yandle, M.G. Nicholls, E.A. Espiner, and A.M. Richards Identification of amino-terminal pro-C-type natriuretic peptide in human plasma Biochem Biophys Res Commun 286 2001 513 517 (Pubitemid 32912975)
79. C.M. Wei, D.M. Heublein, M.A. Perella, A. Lerman, R.J. Rodeheffer, and C.G. McGregor Natriuretic peptide system in human heart failure Circulation 88 1993 1004 1009 (Pubitemid 23264016)
80. S. Del Ry, M. Maltinti, M. Emdin, C. Passino, G. Catapano, and D. Giannessi Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation Clin Chem Lab Med 43 2005 641 645 (Pubitemid 41460615)
81. S. Del Ry, C. Passino, M. Maltinti, M. Emdin, and D. Giannessi C-type natriuretic peptide plasma levels increase in patients with congestive heart failure as a function of clinical severity Eur J Heart Fail 7 2005 1145 1148 (Pubitemid 41721117)
82. S. Del Ry, D. Giannessi, M. Maltinti, C. Prontera, A. Iervasi, and C. Colotti Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction Peptides 28 2007 1068 1073 (Pubitemid 46654449)
83. S. Del Ry, M. Maltinti, M. Cabiati, M. Emdin, D. Giannessi, and M.A. Morales C-type natriuretic peptide and its relation to non invasive indices of left ventricular function in patients with chronic heart failure Peptides 29 2008 79 82 (Pubitemid 50008072)
84. P.R. Kalra, J.R. Clague, A.P. Bolger, S.D. Anker, P.A. Poole-Wilson, and A.D. Struthers Myocardial production of C-type natriuretic peptide in chronic heart failure Circulation 107 2003 571 573 (Pubitemid 36176806)
85. S. Del Ry, M. Maltinti, M. Piacenti, C. Passino, M. Emdin, and D. Giannessi Cardiac production of C-type natriuretic peptide in heart failure J Cardiovasc Med 7 2006 397 399 (Pubitemid 44145618)
86. S. Del Ry, M. Cabiati, V. Lionetti, M. Emdin, F.A. Recchia, and D. Giannessi Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart Peptides 29 2008 2208 2215 (Pubitemid 50311068)
87. S. Del Ry, M. Cabiati, V. Lionetti, A. Simioniuc, C. Caselli, and T. Prescimone Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure Peptides 30 2009 1710 1713
88. S. Del Ry, M. Cabiati, V. Lionetti, and D. Giannessi NPR-B, the C-type natriuretic peptide specific receptor, is the predominant biological receptor in mouse and pig myocardical tissue Minerva Endocrinol 35 2010 37 46
89. M. Cabiati, L. Sabatino, R. Caruso, C. Caselli, T. Prescimone, and D. Giannessi Gene expression of C-type natriuretic peptide and of its specific receptor NPR-B in human leukocytes of healthy and heart failure subjects Peptides 37 2012 240 246
90. M. Cabiati, L. Sabatino, R. Caruso, A. Verde, C. Caselli, and T. Prescimone C-type natriuretic peptide transcriptomic profiling increases in human leukocytes of patients with chronic heart failure as a function of clinical severity Peptides 47C 2013 110 114
91. B. Nazario, R. Hu, A. Pedram, P. Bruce, and E.R. Levin Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells J Clin Invest 95 1995 1151 1157
92. P. Beaulieu, R. Cardinal, P. Page, F. Francoeur, J. Tremblay, and C. Lambert Positive chronotropic an inotropic effects of C-type natriuretic peptide in dogs Am J Physiol 273 1997 H1933 H1940
93. E. Qvigstad, L.R. Moltzau, J.M. Aronsen, C.H. Nguyen, K. Hougen, and I. Sjaastad Natriuretic peptides increase beta1-adrenoceptor signaling in failing hearts through phosphodiesterase 3 inhibition Cardiovasc Res 85 2010 763 772
94. Y. Wang, M.C. de Waard, A. Sterner-Kock, H. Stepan, H.P. Schultheiss, and D.J. Duncker Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice Eur J Heart Fail 9 2007 548 557 (Pubitemid 46702821)
95. S. Del Ry, M. Cabiati, A. Martino, C. Cavallini, C. Caselli, and G.D. Aquaro High concentration of C-type natriuretic peptide promotes VEGF-dependent vas-culogenesis in the remodeled region of infarcted swine heart with preserved left ventricular ejection fraction Int J Cardiol 2013 10.1016/j.ijcard.2013.03. 015 pii: S0167-5273(13)00434-8 (Epub ahead of print)
96. T. Soeki, I. Kishimoto, H. Okumura, T. Tokudome, T. Horio, and K. Mori C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction J Am Coll Cardiol 45 2005 608 616 (Pubitemid 40222257)
97. M.T. Mattingly, R.R. Brandt, D.M. Heublein, C. Wei, A. Nir, and J.C. Burnett Presence of C-type natriuretic peptide in human kidney and urine Kidney Int 46 1994 744 747 (Pubitemid 24272032)
98. E.J. Topol The lost decade of nesiritide N Engl J Med 365 2011 81 82
99. T. Ahmad, and G.M. Felker Subcutaneous natriuretic peptide for treatment of heart failure. A dying therapy reborn? J Am Coll Cardiol 60 2012 2313 2315
100. M. Vaduganathan, S.J. Greene, A.P. Ambrosy, M. Gheorghiade, and J. Butler The disconnect between phase II and phase III trials of dugs for heart failure Nat Rev Cradiol 10 2013 85
101. S. Mangiafico, L.C. Costello-Boerrigter, I.A. Andersen, A. Cataliotti, and J.C. Burnett Jr. Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics Eur Heart J 34 2013 886 893
102. H.H. Chen, J.F. Glockner, J.A. Schirger, A. Cataliotti, M.M. Redfield, and J.C. Burnett Jr. Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide J Am Coll Cardiol 60 2012 2305 2312
103. S. Hayek, and M. Nemer Cardiac natriuretic peptides: from basic discovery to clinical practice Cardiovasc Ther 29 2011 362 376
104. N. Gassanov, E. Biesenbach, E. Caglayan, A. Nia, U. Fuhr, and F. Er Natriuretic peptides in therapy for decompensated heart failure Eur J Clin Pharmacol 68 2012 223 230
105. R. Zakeri, and J.C. Burnett Designer natriuretic peptides: a vision for the future of heart failure therapeutics Can J Physiol Pharmacol 89 2011 593 601
106. R.A. Rose CD-NP, a chimeric natriuretic peptide for the treatment of heart failure Curr Opin Invest Drugs 11 2010 349 356
107. C.Y. Lee, H.H. Chen, O. Lisy, S. Swan, C. Cannon, and H.D. Lieu Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects J Clin Pharmacol 49 2009 668 673